Home › Free Stock Grades › TLSI
TriSalus Life Sciences, Inc. (TLSI) Stock Grade
TLSI · Healthcare
C
Market Cap
$270.3M
P/E Ratio
—
Revenue Growth (YoY)
+53.4%
Net Margin
-86.9%
Return on Equity
115.8%
Dividend Yield
None
About TriSalus Life Sciences, Inc.'s fundamentals
TriSalus Life Sciences is a medical device company with a market capitalization of $270.3 million that is experiencing rapid revenue expansion, growing 53.4% year-over-year. However, the company is currently unprofitable, with a net margin of -86.9% and reported a net loss in its latest annual statement, indicating that expenses significantly exceed revenues. The company does not pay a dividend, and the standard P/E ratio is not applicable given the loss position. The elevated return on equity figure of 115.8% should be interpreted cautiously given the company's negative earnings environment.